The funding is being provided through the Massachusetts Life Sciences Center, which oversees the state's $1 billion life sciences investment plan.
The competition was established in 2015 to fund studies addressing the biggest challenges in cancer research.
The agency aims to fund projects that will use functional genetics and genomics to gain insights into the molecular underpinnings of substance use disorders.
The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.
The platform will be based on the company's PicoSep DNA and RNA sizing instrument.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.